Mylan Raises Bid for Meda to 145 Kroner/Share, Shares Gain 3%

Shares of

have jumped 3 percent in Friday's trading following a

that Mylan has boosted its bid for rival Swedish drugmaker Meda from 130 Kroner/share to 145 Kroner/share. Meda shares rose 10 percent on the news before the stock was halted. Mylan has been hot in 2014, up 19.5 percent year-to-date. Merger & acquisition activity has been dominating the headlines recently, with

acquiring Biomet, and

making a hostile bid for

.